Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Morepen Laboratories Ltd

Morepen Laboratories Ltd share price and stock overview

Morepen Laboratories Ltd (NSE: MOREPENLAB, BSE: 500288) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE083A01026 and a face value of Rs 2. As of 01 October 2026, it trades at Rs (125.99) with a market capitalisation of Rs 6509.69 crore. Figures are live and subject to change.

Morepen Laboratories Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
125.99 7.19 (6.05%) upARrowC
As on: 01-Oct-2026 , 02:49 AM
Market Cap(₹Cr) 6509.69
Book Value(₹Cr) 22.6801122
BSE Code : 500288 NSE Symbol : MOREPENLAB EPS(TTM) : 2.03 ISIN Demat : INE083A01026 P/E(TTM) : 58.52 Face Value(₹) : 2 Div & Yield % : 0.17

Today Market

Stock Performance

Today Market

Today's High

73,062.23

Todday's Low

72,366.44

Open at

72,441.15

Previous Close

72,529.07

Volumes

Avg Price

-48.78

Historical Performance

News

28 Sep 26
Morepen Laboratories will halt trading ahead of financial results announcement in late September 2026
Morepen Laboratories Limited will close its trading window from October 1, 2026, until 48 hours after the announcement of its unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2026, in accordance with SEBI regulations and the company’s insider trading policy.
12 Aug 26
Morepen Laboratories Ltd fixes record date for Final dividend
Morepen Laboratories Ltd fixes record date for Final dividend Record date is 19 September 2026 Morepen Laboratories Ltd has fixed 19 September 2026 as record date for payment of final dividend of Rs 0.
06 Aug 26
Morepen Laboratories subsidiary Morepen RX allotted shares totaling Rs 20 crore through a rights issue
Morepen Laboratories Limited announced that its wholly owned subsidiary, Morepen RX Limited (MRX), has allotted 20,00,00,000 equity shares with a face value of Rs 10 each, totaling Rs 20,00,00,000, to the company through a rights issue.
04 Aug 26
Morepen Laboratories Ltd consolidated sales up 17.62% on year in Q2FY2026, net profit jumped 258.92%
Morepen Laboratories Ltd share price ticked higher by 1.19% to Rs 57.68 after the company's net profit soared by 258.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
30-09-26 119.34 128.10 117.80 125.99 26169666 87431 3247626966.07 22620.45
29-09-26 120.80 122.69 117.37 118.80 12759041 50923 1527023006.86 22716.20
28-09-26 121.15 126.22 119.42 120.71 19123218 78443 2355341863.81 22780.25
25-09-26 117.30 121.00 117.00 120.38 8996779 36703 1073037867.78 23140.50
24-09-26 121.94 122.57 115.56 116.60 9209711 37844 1093373270.80 23063.10
23-09-26 119.48 124.47 118.01 122.35 11266057 45449 1378432759.81 23446.80
22-09-26 122.35 123.80 118.12 119.04 10361426 41212 1248751394.99 23329.00
21-09-26 120.90 126.80 120.80 122.35 17854846 69141 2213378214.34 23414.30
18-09-26 120.60 123.45 118.14 120.90 16816327 66306 2028617945.31 23346.40
17-09-26 115.00 121.30 112.62 120.56 27513682 111748 3263719432.49 23270.60
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

6509.69

PE Ratio

58.52

PB Ratio

5.24

Dividend Yield

0.17

ROE

5.45

ROCE

7.20

Book Value (₹)

22.6801122

Face Value (₹)

2

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 154129838 28.13 154129838 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41241750 7.53 41241750 24
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 195371588 35.65 195371588 35
Total ShareHolding for Promoter & Group 195371588 35.65 195371588 35
plus   Publice Share Holding
plus  Institution
Government(Central / State) 60000 0.01 60000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1706657 0.31 1706657 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8002750 1.46 8002750 38
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5143530 0.94 5143530 4
Mutual Funds / UTI 15225 0.00 15225 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 163380 0.03 163380 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 15091542 2.75 15091542 49
plus  Non Institution
Bodies Corporate 11996633 2.19 11363262 730
Clearing Members 1675109 0.31 1675109 64
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6706795 1.22 6705138 3332
Foreign Non Institution Other 38893097 7.10 38893097 4
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 31735536 5.79 26917641 99
Individuals holding nominal share capital up to Rs. 1 lakh 240877424 43.96 220472296 430592
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 28831 0.01 28831 6
Others 0 0.00 0 0
Sub Total 337490569 61.59 311632518 434828
Total Public Shareholding 352582111 64.35 326724060 434877
Total of Promoter & Public ShareHolding 547953699 100.00 522095648 434912
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 547953699 100.00 522095648 434912

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales1,805.691,811.581,690.431,417.531,546.83
OPM (%)5.218.568.013.938.19
OP94.09155.11135.4255.76126.70
Other Income21.3118.3613.976.1310.31
PBIDT172.77192.43172.6085.67146.98
INTEREST16.418.343.711.98-7.37
PBDT156.35184.09168.8983.69154.35
PBT145.75155.11135.4255.76126.70
EO25.830.000.000.000.00
PBT after EO119.92155.11135.4255.76126.70
TAXES24.2737.0938.8017.0825.02
PAT94.88118.0296.1638.68101.68
EPS1.732.201.880.771.96
Raw Material57.7755.1652.2555.1251.53
Power and Fuel2.492.242.021.681.22
Employee Cost12.8911.5310.7310.9110.62
Other Manufacturing Expenses0.950.880.000.000.00
Selling and Administration Expenses9.838.3310.9411.446.94
Miscellaneous Expenses2.131.381.601.353.34
Revenue (Growth %) -0.327.1719.25-8.3630.20
PBIDT (Growth %)-10.2211.49101.47-41.7212.56
PAT (Growth %) -19.6122.73148.63-61.964.73
PBIDT (Margin %)9.5710.6210.216.049.50
PAT (Margin %) 5.256.515.692.736.57

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 109.58109.58102.23102.2395.5689.96
Reserves Total 1133.171071.92786.80677.89476.36311.26
Equity Share Warrants0.000.000.000.0026.2543.75
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds1242.751181.50889.03780.12598.17444.97
Secured Loans 44.2453.9628.1925.1618.5717.05
Unsecured Loans 160.3341.550.000.000.000.00
Total Debt204.5795.5128.1925.1618.5717.05
Other Liabilities165.9536.8232.0330.8328.6026.06
Total Liabilities1613.271313.83949.25836.11645.34488.08
APPLICATION OF FUNDS :
Gross Block 664.91648.76477.36512.07479.46516.17
Less : Accumulated Depreciation 262.27282.88260.83341.25323.35372.14
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 402.64365.88216.53170.82156.11144.03
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress8.2228.3424.4517.0114.151.96
Producing Properties0.000.000.000.000.000.00
Investments 110.04204.97126.18117.84117.79118.78
Current Assets, Loans & Advances
Inventories 257.23286.39220.15211.35258.25169.61
Sundry Debtors 333.19293.75316.89255.47221.87155.52
Cash and Bank Balance59.4046.3350.4855.9045.5566.98
Loans and Advances 263.06402.51255.40208.12151.09100.68
Total Current Assets912.881028.98842.91730.85676.76492.79
Less : Current Liabilities and Provisions
Current Liabilities 269.87382.79304.76251.83375.83355.37
Provisions 8.0317.6023.0514.919.614.05
Total Current Liabilities & Provisions277.91400.39327.81266.74385.44359.42
Net Current Assets634.98628.59515.10464.11291.33133.38
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets15.9815.6410.389.579.180.00
Deferred Tax Liability32.4622.6212.6312.2611.670.00
Net Deferred Tax-16.48-6.98-2.25-2.69-2.490.00
Other Assets473.8893.0469.2369.0268.4589.95
Total Assets1613.271313.83949.25836.11645.34488.09
Contingent Liabilities335.4016.237.096.661.640.93

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 66.41144.200.28260.4797.12
Investing Activities -22.64-36.20-83.60-280.42-119.02
Net Cash Flow -25.095.88-5.969.12-1.43
Operating Activities -68.87-102.1277.3629.0820.47

Peers

Balance Sheet Financial Ratios Profit & Loss
Aarti Pharmalabs...

953.75

(-1.96%)
Accent Microcell...

674.65

(+0.10%)
Accretion Pharma...

214.00

(+1.45%)
Achyut Healthcar...

Advanced Enzyme ...

281.60

(-0.19%)
Akums Drugs & Ph...

818.50

(-0.13%)
Albert David Ltd

872.25

(-0.47%)
Alembic Pharmace...

825.45

(-4.18%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
SS
Sushil Suri
Chairman / Executive Director / M D / Promoter
Executive
Functional Directors
SS
Sanjay Suri
WTD & Executive Director
Exec.
Independent Directors
PKD
Praveen Kumar Dutt
Independent Non Exe. Director
Ind.
RK
Ranjit Khattar
Independent Non Exe. Director
Ind.
S
Savita
Independent Non Exe. Director
Ind.
SJ
Sharad Jain
Independent Non Exe. Director
Ind.
Company Secretary & Compliance
VKS
Vipul Kumar Srivastava
Company Secretary
Sec.

Frequently Asked Questions

What is the NSE symbol and BSE code for Morepen Laboratories Ltd? −

Morepen Laboratories Ltd trades on NSE under MOREPENLAB and on BSE under code 500288. The ISIN is INE083A01026 and the face value is Rs 2.

What is the share price of Morepen Laboratories Ltd today? +

As of 01 October 2026, Morepen Laboratories Ltd trades at Rs 125.99, a change of 7.19 (6.05%) on the day. Prices are live and subject to change.

What is the market capitalisation of Morepen Laboratories Ltd? +

As of 01 October 2026, Morepen Laboratories Ltd has a market cap of about Rs 6509.69 crore. This figure is live and moves with the share price.

Is Morepen Laboratories Ltd profitable? +

In March 2026, Morepen Laboratories Ltd reported a profit after tax of Rs 94.88 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Morepen Laboratories Ltd? +

: As of 01 October 2026, the PE (TTM) for Morepen Laboratories Ltd is 58.52 and the price-to-book ratio is 5.24. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Morepen Laboratories Ltd pay a dividend? +

As of 01 October 2026, the dividend yield for Morepen Laboratories Ltd is 0.17%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Morepen Laboratories Ltd? +

As of the latest disclosed pattern, promoters hold 35.65% of Morepen Laboratories Ltd. Public shareholding is 64.35%, including mutual funds at 0.00% and foreign institutional investors at 1.46%.

What were the latest annual financials of Morepen Laboratories Ltd? +

In March 2026, Morepen Laboratories Ltd reported net sales of Rs 1,805.69 crore, revenue growth of -0.32%, and earnings per share of Rs 1.73.